Abstract:Bufadienolides are a class of steroids with a distinctive α-pyrone ring at C17, mostly produced by toads and consisting of over 100 orthologues. They exhibit potent cardiotonic and antitumor activities and are active ingredients of the traditional Chinese medicine Chansu and Cinobufacini. Direct extraction from toads is costly, and chemical synthesis is difficult, limiting the accessibility of active bufadienolides with diverse modifications and trace content. In this work, based on the transcriptome and genome analyses, using a yeast-based screening platform, we obtained eight cytochrome P450 (CYP) enzymes from toads, which catalyze the hydroxylation of bufalin and resibufogenin at different sites. Moreover, a reported fungal CYP enzyme Sth10 was found functioning in the modification of bufalin and resibufogenin at multiple sites. A total of 15 bufadienolides were produced and structurally identified, of which six were first discovered. All of the compounds were effective in inhibiting the proliferation of tumor cells, especially 19-hydroxy-bufalin (2) and 1β-hydroxy-bufalin (3), which were generated from bufalin hydroxylation catalyzed by CYP46A35. The catalytic efficiency of CYP46A35 was improved about six times and its substrate diversity was expanded to progesterone and testosterone, the common precursors for steroid drugs, achieving their efficient and site-specific hydroxylation. These findings elucidate the key modification process in the synthesis of bufadienolides by toads and provide an effective way for the synthesis of unavailable bufadienolides with site-specific modification and active potentials.

New cytotoxic bufadienolides from the biotransformation of resibufogenin by Mucor polymorphosporus

Microbial Transformation of Three Bufadienolides by Nocardia Sp. and Some Insight for the Cytotoxic Structure–activity Relationship (SAR)

Novel cytotoxic bufadienolides derived from bufalin by microbial hydroxylation and their structure-activity relationships.

Cytotoxic Resibufogenin Transformation Products from Cell Suspension Cultures of Platycodon Grandiflorum

Highly selective isomerization and dehydrogenation of three major bufadienolides at 3-OH by Fusarium solani

New Cytotoxic 19-Norbufadienolide and Bufogargarizin Isolated from Chan Su

Cytochrome P450 Mining for Bufadienolide Diversification

Microbial Hydroxylation of Bufalin by Cunninghamella Blakesleana and Mucor Spinosus.

Substrate Specificity for the 12 Beta-Hydroxylation of Bufadienolides by Alternaria Alternata

Structurally diverse bufadienolides from the skins of Bufo bufo gargarizans and their cytotoxicity

Efficient Preparation of Derivatives of Resibufogenin Using Microbial Catalytic Technique

Directional modifications of resibufogenin by Mucor subtilissimus and Pseudomonas aeruginosa

Microbial transformation of cinobufagin by Syncephalastrum racemosum.

Enzymatic Synthesis of Bufadienolide O‐Glycosides as Potent Antitumor Agents Using a Microbial Glycosyltransferase

Biotransformation of arenobufagin and cinobufotalin by Alternaria alternata

Biotransformation of Bufadienolides by Cell Suspension Cultures of Saussurea Involucrata

Biotransformation of Cinobufagin by Cell Suspension Cultures of Catharanthus Roseus and Platycodon Grandiflorum

Two New Compounds Derived from Bufalin

Microbial hydroxylation of cinobufagin by Mucor spinosus.

Microbial Transformation of Bufotalin by Alternaria Alternata As 3.4578

Selective dehydrogenation of resibufogenin and cinobufagin at 3-OH by Pseudomonas aeruginosa